In the Mix: 6 More Articles — June 03, 2026
This cannabis clinical commentary June 2026 reviews six recent articles relevant to cannabis medicine and healthcare. The digest highlights the challenges in integrating cannabis into clinical practice. It underscores the need for rigorous evidence-based…
Scientist explains ‘only two methods’ to stop weed smoker’s horrific ‘scromiting’ side effect
✦ New CED Clinical Relevance #76 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchTHCSafetyNeurologyMental HealthDosingEndocannabinoid System Why This Matters Cannabinoid Hyperemesis…
Amendments To Keep Hemp THC Products Federally Legal Won’t Get Votes … – Marijuana Moment
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyHempTHCCancerResearchSafetyIndustry Why This Matters Clinicians should be aware that proposed federal…
Beshear clarifies list of qualified conditions for Kentucky’s medical marijuana program
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyNeurologyPainCancerMental HealthAnxietySleep Why This Matters Kentucky clinicians now have clear regulatory…
Cannabis companies hid health issues from consumers: Federal lawsuit – NewsNation
✦ New CED Clinical Relevance #81 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyIndustryMental HealthPolicyTHCNeurology Why This Matters Clinicians need to understand that cannabis…
New Insights on GLP-1 Receptor Agonist Side Effects from Patient Reports
This analysis focuses on GLP-1 receptor agonist patient-reported side effects gathered from real-world evidence. It highlights emerging safety signals beyond traditional clinical trial data. Clinicians should consider these findings to improve patient…
Comparing Liraglutide and Tirzepatide: Clinical Evidence for Weight Loss
This article presents liraglutide tirzepatide clinical comparison weight loss evidence, highlighting tirzepatide's dual agonist advantage. Tirzepatide achieves greater weight reduction than liraglutide in trials. Understanding these differences supports…
Clinical Evidence and Safety of Semaglutide for Weight Management
Semaglutide chronic weight management is supported by robust clinical evidence demonstrating significant weight loss and metabolic benefits. This GLP-1 receptor agonist is FDA-approved for adults with obesity or overweight with related conditions.…
In the Mix: 7 More Articles — June 03, 2026
This digest highlights the Kentucky medical cannabis qualifying conditions expansion in 2026, detailing 15 new conditions added. Clinicians should monitor these changes for clinical relevance and patient care. The expansion reflects ongoing state-level…
Gov. Beshear expands medical cannabis access, adding 15 new qualifying conditions
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyMedical CannabisPainAnxietyMental HealthNeurologyCancer Why This Matters Clinicians in Kentucky can now…